Author:
Garcia de Lucas M.D.,Olalla Sierra J.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference11 articles.
1. Standards of Medical Care in, Diabetes—2016;American Diabetes Association;Diabetes Care,2016
2. SGLT2 inhibitors or GLP-1 receptor agonists as second line therapy in type 2 diabetes: patient selection and perspectives;Gurgle;Vasc Health Risk Manag,2016
3. Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials;Fonseca;J Diabetes Complications,2014
4. SGLT-2 inhibitor therapy added to glp-1 agonist therapy in the management of t2dm;Saroka;Endocr Pract,2015
5. Positioning SGLT2 inhibitors/incretin-based therapies in the treatment algorithm;Wilding;Diabetes Care,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献